Menu

Allele Linked to Obesity in People

A single nucleotide polymorphism in BDNF is tied with lower levels of the protein and higher body-mass index.

Nov 3, 2015
Kerry Grens

FLICKR, TONY ALTERThe gene for brain-derived neurotropic factor (BDNF)—important for neuronal health and also implicated in appetite—has been associated with obesity in humans, and scientists have now figured out why. An allele of BDNF, called C, leads to lower protein levels because of disrupted binding to a transcription factor.

“Lower BDNF levels may contribute to obesity in people with the C allele. If these findings are supported by additional studies, boosting BDNF levels may prove beneficial,” lead author Joan Han of the University of Tennessee Health Science Center said in a press release.

Hans’s group combed through the genetic and health data of more than 31,000 people, finding that those with the C allele—caused by a single nucleotide polymorphism (SNP)—were more likely to have increased body fat and a higher body-mass index (BMI). The team also analyzed postmortem tissue from 84 people and found lower BDNF levels in the hypothalamus among those with the CC genotype.

In the lab, Hans and her colleagues found that a transcription factor binds to BDNF at the site on the typical allele where the SNP occurs. The SNP in the C allele reduces this binding, they showed last week (October 29) in Cell Reports.

“This study explains how a single genetic change in BDNF influences obesity and may affect BDNF protein levels. Finding people with specific causes of obesity may allow us to evaluate effective, more-personalized treatments,” study coauthor Jack Yanovski, an investigator at the National Institutes of Health’s Eunice Kennedy Shriver National Institute of Child Health and Human Development, said in the press release.

September 2018

The Muscle Issue

The dynamic tissue reveals its secrets

Marketplace

Sponsored Product Updates

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery introduces Myeloid DNA Reference Standard to support genetic testing of leukemia

Horizon Discovery Group plc, a global leader in gene editing and gene modulation technologies, today announced the launch of its Myeloid DNA Reference Standard. The first-to-market large cell-line derived myeloid cancer reference standard designed enables faster, more reliable and more cost-effective assay validation, to support the market in bringing routine testing into practice.

StemExpress LeukopakâNow Available in Frozen Format

StemExpress LeukopakâNow Available in Frozen Format

StemExpress, a Folsom, California based leading supplier of human biospecimens, announces the release of frozen Peripheral Blood Leukopaks. Leukopaks provide an enriched source of peripheral blood mononuclear cells (PBMCs) with low granulocyte and red blood cells that can be used in a variety of downstream cell-based applications.

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

New Antifade Mounting Media from Vector Laboratories Enhances Immunofluorescence Applications

Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces VECTASHIELD® Vibrance™ – antifade mounting media that delivers significant improvements to the immunofluorescence workflow.

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Best Practices for Sample Preparation and Lipid Extraction from Various Samples

Download this white paper from Bertin Technologies to learn how to extract and analyze lipid samples from various models!